Reports for AMPHASTAR PHARMACEUTICALS, INC.

Company Name

AMPHASTAR PHARMACEUTICALS, INC.

Totals

Shortage reports

12

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 12 (100%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

2 (17%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BAQSIMI 3MG POWDER Resolved 2024-02-22 2024-02-28 220276
BAQSIMI 3MG POWDER Resolved 2024-08-20 2024-09-23 235530
BAQSIMI 3MG POWDER Resolved 2024-10-10 2024-10-23 239831
BAQSIMI 3MG POWDER Resolved 2024-11-11 2024-11-20 242464
BAQSIMI 3MG POWDER Resolved 2025-01-06 2025-03-19 246858
BAQSIMI 3MG POWDER Resolved 2025-04-16 2025-05-02 255162
BAQSIMI 3MG POWDER Resolved 2025-05-05 2025-07-16 256705
BAQSIMI 3MG POWDER Resolved 2025-07-29 2025-08-13 263741
CORTROSYN INJ 0.25MG 0.25MG POWDER FOR SOLUTION Resolved 2018-01-17 2018-04-04 36165
CORTROSYN INJ 0.25MG 0.25MG POWDER FOR SOLUTION Resolved 2021-10-22 2022-01-19 147831
CORTROSYN INJ 0.25MG 0.25MG POWDER FOR SOLUTION Resolved 2022-02-11 2022-04-30 154776
CORTROSYN INJ 0.25MG 0.25MG POWDER FOR SOLUTION Resolved 2022-05-20 2022-06-28 161043

Showing 1 to 12 of 12

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0